Bedel Financial Consulting, Inc. Fsd Pharma Inc. Transaction History

Bedel Financial Consulting, Inc.

  • $716 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 04, 2022
SELL
$0.78 - $1.1 $19 - $27
-25 Closed
0 $0
Q1 2021

Apr 26, 2021
BUY
$1.65 - $3.87 $41 - $96
25 New
25 $0

About FSD Pharma Inc.

HUGE Quotes by TradingView
  • Ticker HUGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 38,218,100
  • Market Cap $146M
  • Description
  • FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also focuses on Lucid-PSYCH, a psychoactive molecule identified for the potential treatment of neuropsychiatric disorders, such...
More about HUGE
Track This Portfolio

Track Bedel Financial Consulting, Inc. Portfolio

Follow Bedel Financial Consulting, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bedel Financial Consulting, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bedel Financial Consulting, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email